EVMN · Evommune, Inc. · Documents
$5.25
-0.13 (-2.42%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$195.25M
Shares
36.29M
Volume · Oct 21
193.38K
Avg daily vol (3M)
676.59K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-10-01 | — | |
| 8-K | — | 2026-09-23 | — | |
| 8-K | — | 2026-09-15 | — | |
| 8-K | — | 2026-09-09 | 2026-09-08 | |
| 8-K | — | 2026-08-06 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-07-30 | 2026-07-29 | |
| 8-K | — | 2026-06-29 | — | |
| Investor Event Transcript | — | 2026-06-02 | 2026-06-30 | |
| 8-K | — | 2026-06-02 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| 8-K | — | 2026-05-07 | — | |
| ARS | — | 2026-04-21 | 2025-12-31 | |
| DEF 14A | — | 2026-04-21 | — | |
| DEFA14A | — | 2026-04-21 | — | |
| S-1 | — | 2026-04-17 | — | |
| 8-K | — | 2026-04-13 | — | |
| Investor Event Transcript | — | 2026-04-13 | 2026-06-30 | |
| 10-K | — | 2026-03-05 | 2025-12-31 | |
| 8-K | — | 2026-03-05 | — | |
| 8-K | — | 2026-02-13 | 2026-02-12 | |
| 8-K | — | 2026-02-10 | — | |
| 8-K | — | 2025-12-11 | — | |
| 10-Q | — | 2025-12-11 | 2025-09-30 | |
| 8-K | — | 2025-11-07 | — | |
| S-1/A | — | 2025-10-17 | — | |
| S-1 | — | 2025-10-09 | — |
Showing 1–27 of 27 filings